The slides are offered for use by any agent of change management seeking to address improvements in management of polypharmacy. The slides are fully editable to enable the specific context of the initiative in different organisational, regional and national settings to be edited or added. These slides provide material and ideas for developing and communicating the vision for polypharmacy management.
Download the slides: Management of Polypharmacy - VISION for 2025
This spreadsheet tool enables a cost benefit analysis estimation based on implementing prescription reviews. This can be used to support the case for change and will be of particular interest to finance managers in healthcare organisations.
This guide details now to use the tool and the options available should there be a lack of existing data in your country or region.
This document provides ideas and specific context for stakeholders considering or embarking upon a programme aimed at improving polypharmacy management.
PESTEL can be a useful tool to help agents of change understand the factors creating uncertainty within the relevant environment. This document provides examples of these uncertainties within the context of polypharmacy and offers a framework for performing PESTEL analysis.
This report sets out the case for prioritising working together now to address inappropriate medication use over the next decade, to ensure the quality, economic and political systems are put in place to improve medication safety for patients. There are encouraging signs of the increasing recognition of these challenges, and the timeliness of this report. In March 2017, the World Health Organisation (WHO) launched a global challenge to address medication safety, with polypharmacy as a flagship element. A special interest group will be launched by the International Foundation on Integrated Care in May 2017.
This defines the available guidance and relevant literature related to polypharmacy management.
A benchmarking survey across the EU uncovers the lack of awareness and absence of data related to the polypharmacy management.
Download: Polypharmacy Benchmarking Survey Report
The aim of the consensus study was to determine the levels of consensus amongst key stakeholders in the EU in relation to aspects of the management of polypharmacy and adherence in older people. Forty-six statements for the first round of the Delphi were developed from the findings generated from SIMPATHY Work Packages 4, 5 and 6, focusing on structures, processes and outcomes around the promotion of appropriate polypharmacy and adherence in older people. Consensus was deemed to have been met at 80% (summative of agree and strongly agree) for each individual statement.
Transforming Awareness into Action: Implementing effective management of the use of multiple medications across the EU.
Download the Flyer: Polypharmacy Programmes